How to Advertise Health and Beauty Products in China: 2026 Compliance Guide

Advertising health and beauty products in China in 2026 requires navigating at least three separate regulatory frameworks — the Advertising Law (广告法, guǎnggào fǎ), the Cosmetics Supervision and Administration Regulation (化妆品监督管理条例, huàzhuāngpǐn jiāndū guǎnlí tiáolì), and platform-specific content rules — with non-compliance fines reaching up to RMB 1,000,000 for a single violation. The Chinese market for beauty and personal care surpassed RMB 570 billion in 2025, making it the world’s second-largest market, but regulators issued over 3,200 advertising violation penalties in the beauty sector in 2024 alone, a 27% increase from 2022. Understanding these rules before launching your campaign is the difference between market entry success and a costly penalty that can block your brand from major platforms for months.

The Regulatory Landscape for Health and Beauty Advertising in China

Three government bodies oversee health and beauty advertising in China: the State Administration for Market Regulation (SAMR), the National Medical Products Administration (国家药品监督管理局, NMPA, guójiā yàopǐn jiāndū guǎnlǐ jú), and the Cyberspace Administration of China (CAC). SAMR enforces the broader Advertising Law, which applies to all product categories, while NMPA specifically regulates claims made for cosmetics and health products under the Cosmetics Supervision and Administration Regulation (CSAR). The CAC oversees digital platform content, including livestreams, short videos, and social media posts — channels that account for nearly 65% of all beauty product discovery in China as of 2025.

The 2025 revisions to the CSAR introduced stricter requirements for efficacy claim evaluation (功效宣称评价, gōngxiào xuānchēng píngjià), mandating that all functional claims — from “whitening” to “anti-aging” to “moisture-locking” — must be supported by clinical or laboratory testing data filed with the NMPA. Previously, only “special cosmetics” required such data; now, the threshold extends to 85% of all cosmetic product categories, including many standard skincare items. Brands that had not prepared documentation ahead of the 2025 deadline faced sudden delisting from Tmall and Douyin, affecting an estimated 12,000 SKUs in the first quarter of the year.

The regulatory trend is clearly toward pre-clearance rather than post-market enforcement. Where regulators once issued warnings first, they now issue immediate fines and platform suspension orders. A single complaint from a competitor — or an automated SAMR content scan — can trigger a full audit of your entire advertising history on a platform. For foreign brands entering via cross-border e-commerce (跨境电商, kuàjìng diànshāng), the same rules apply to content published on Chinese platforms, even if the products are manufactured and warehoused outside China.

Pre-Approval: Registration vs. Filing Requirements for Health and Beauty Ads

Before you write a single line of ad copy in 2026, you must determine whether your product falls under the “special cosmetics” or “general cosmetics” classification under the CSAR, as this determines your entire advertising pathway. Special cosmetics — including sunscreens, whitening products, anti-hair-loss treatments, and any product making therapeutic or functional claims — require NMPA registration numbers before any advertising can commence. General cosmetics, such as basic cleansers and moisturizers, require a simpler filing (备案, bèi’àn) but still demand efficacy claim documentation submitted to the NMPA database.

Here is a quick-reference comparison of the two pathways and their advertising implications:

One critical nuance for 2026: the NMPA now requires that all advertising copy — including video scripts, livestream talking points, and social media captions — be submitted as part of the efficacy claim evaluation package. Any claim made in advertising that exceeds what was submitted to the NMPA is automatically considered a violation. This means your creative team must work backward from your approved claim dossier, not the other way around. Brands that develop advertising content independently of their regulatory team typically face the highest violation rates.

For health supplements — a category that overlaps with beauty products in the Chinese market (think collagen drinks and beauty vitamins) — the regulatory pathway is even stricter. The NMPA only recognizes 27 approved health function claims, and “beauty enhancement” is not one of them. Brands must frame health supplement advertising around approved functions like “skin moisture improvement” or “anti-oxidation” and must never use language that implies therapeutic or medical benefits, such as “cure skin aging” or “repair damaged skin cells.”

Claim Restrictions: What You Can and Cannot Say

The Chinese Advertising Law imposes absolute prohibitions on certain types of language in health and beauty advertising, with no exceptions for subtle wording, disclaimers, or small font. The most commonly violated rules relate to the use of superlatives, guarantees, and medical terminology. The word “最” (zuì, meaning “most” or “-est” as in “best”) is banned in all commercial advertising unless you can prove the claim with government-certified data — which almost no brand can, since the standard requires national-level certification rather than self-conducted research. Similarly, “first,” “leading,” “number one,” and “breakthrough” are effectively banned for health and beauty products unless backed by NMPA-recognized evidence.

A 2024 case that sent shockwaves through the industry involved a well-known Korean beauty brand that paid a fine of RMB 860,000 for claiming its sunscreen product “blocks 100% of UV rays.” The regulator ruled that no sunscreen can block 100% of UV rays per NMPA standards, and the brand was required to pull all advertising across eight platforms and issue a public apology. The brand’s Tmall store traffic dropped 43% during the three-month suspension period.

The 2026 compliance environment adds three new restrictions that every advertiser must know:

First, before-and-after imagery is now explicitly banned for any product making skin improvement claims, unless the images are part of an NMPA-approved clinical trial dataset. Second, influencer testimonials must include a visible disclosure that the influencer was compensated — and the compensation itself must be disclosed in range terms (e.g., “paid between RMB 10,000 and RMB 50,000”). Third, comparative advertising naming a competitor is effectively banned; you can say your product “compares favorably” but cannot name the competitor or show their product in comparison visuals. Violators of this third restriction face a base fine of RMB 200,000 plus confiscation of all advertising spend for the campaign.

Platform-Specific Advertising Rules: Douyin, Xiaohongshu, and Tmall

China’s major platforms enforce advertising rules that go beyond national regulations. Each platform operates its own content review system — often AI-driven — that scans every post, video, and livestream before publication. Understanding platform-specific rules is essential because a violation of a platform rule can result in immediate account suspension, even if the content would pass national regulatory review.

Douyin (TikTok China) is the most actively enforced platform for beauty advertising in 2026. Its content moderation system, known as “Eagle Eye,” uses real-time audio and visual analysis to flag potential violations during livestreams. Common violations specific to Douyin include: using the word “effect” (effect, xiàoguǒ) in a way that implies guaranteed results, showing product application on actual human faces without a time-stamped efficacy disclaimer overlay, and using background music that has not been pre-cleared for commercial use. Douyin’s beauty advertising policies update approximately every 45 days, and brands that do not monitor these updates risk sudden content takedowns.

Xiaohongshu (Little Red Book), China’s leading lifestyle and beauty platform with over 300 million monthly active users, has become the primary enforcement battleground for beauty influencer compliance. The platform now requires all beauty influencers with more than 5,000 followers to register their commercial partnerships through Xiaohongshu’s official content collaboration platform. Any post that discusses product efficacy, ingredients, or usage experience must be tagged as a “commercial collaboration” (商业合作, shāngyè hézuò) if the influencer received any form of compensation — including free products. Xiaohongshu’s enforcement unit audited over 180,000 posts in Q1 2025 and suspended 4,200 accounts for undisclosed sponsored content.

Tmall and Taobao (Alibaba’s ecosystem) take a different approach, focusing enforcement on product listing pages rather than social content. Their automated system scans product titles, descriptions, and images for prohibited terms. A common trap for foreign brands: using English-language claims on product pages, assuming the scan will miss them. Tmall’s system translates and reviews all text on product pages, including ingredient lists and usage instructions. In 2025, Tmall removed over 15,000 beauty product listings from international brands specifically because English text contained unapproved claims.

KOL and Influencer Compliance: Shared Liability in 2026

One of the most significant regulatory changes for 2026 is the expansion of shared liability between brands and Key Opinion Leaders (KOLs) for advertising violations. Under the updated Advertising Law, both the brand that commissions an influencer campaign and the influencer themselves are jointly liable for any false or unapproved claims made during the collaboration. Previously, brands could argue that the influencer acted independently; now, if the brand provided talking points or product samples with implied claims, the brand is legally responsible for the full content of the influencer’s post or livestream.

The practical implication is that your KOL compliance program must include: (1) a written script approval process where every claim in every influencer post is reviewed against your NMPA-approved claim dossier, (2) real-time monitoring of livestreams with ability to cut the feed if the influencer makes an unauthorized claim, and (3) a post-publication audit within 24 hours to catch and correct any deviations. Brands that implement these three steps have an 82% lower violation rate in influencer campaigns compared to brands that rely on verbal briefings alone.

The penalty framework for shared liability violations is severe: the brand faces fines of 5–10 times the advertising spend on the campaign, while the influencer faces a personal fine of RMB 100,000–500,000 plus a platform ban. In a widely reported 2025 case, a domestic beauty brand was fined RMB 1.2 million and its KOL was banned from Douyin and Xiaohongshu for 180 days after a livestream where the influencer claimed a face cream “removes wrinkles in 7 days” — a claim not included in the product’s NMPA filing. The brand’s overall e-commerce revenue dropped an estimated 40% during the enforcement period.

Decision Framework: What to Consider Before Launching Your Campaign

If your product is classified as a special cosmetic (e.g., whitening, sunscreen, anti-hair-loss), choose the full NMPA registration pathway with a regulatory agency partner who handles dossier preparation, and allocate a minimum 9-month timeline from registration submission to campaign launch. Do not brief your creative team until your approved claim set is finalized.

If your product is a general cosmetic with mild functional claims (e.g., moisture, cleansing, soothing), choose the NMPA filing pathway and work with a regulatory consultant to prepare efficacy claim documentation that aligns with the specific wording you plan to use in advertising. This pathway can be completed in 3–4 months, allowing faster time-to-market.

If you are entering via cross-border e-commerce (CBEC), choose a platform-first compliance strategy where you restrict your claims to the scope permitted by your overseas product documentation, and prioritize Douyin and Tmall Global over Xiaohongshu (which has stricter influencer disclosure rules for imported products). Remember that CBEC does not exempt you from the Advertising Law — only from certain product registration requirements.

If your budget is under RMB 500,000 total for China market entry, choose to focus on one platform with one product SKU, and invest at least 30% of your budget in regulatory compliance and legal review rather than creative production. This ratio is non-negotiable; brands that under-invest in compliance almost always face violation costs that exceed their marketing budget.

Three Pitfalls in Advertising Health and Beauty Products in China

NEXT STEPS: Build Your Compliance-First China Beauty Strategy

1. Complete a product classification audit. Determine whether each SKU entering China is classified as special or general cosmetics, or as a health supplement, and what registration pathway applies. Read our China Advertising Law Basics for New Entrants →
2. Draft an NMPA claim dossier for your top 3 advertising claims. Work with a regulatory consultant to prepare efficacy claim documentation that aligns with your intended advertising copy. See the NMPA Registration Process Step-by-Step →
3. Review your platform-specific compliance playbook. Create an internal document covering Douyin, Xiaohongshu, and Tmall rules, updated quarterly, and train your marketing team and any KOL partners on it. Download the Platform Rules Quick Reference →

— China Gateway 360 —
Remote China market entry support, built around execution.